Tag: Diethylcarbamazine

Worldwide, parasitic infections affect millions of people, causing a range of health issues from minor discomfort to serious, long-term disability. The Trozan Tablet, whose active ingredient is Diethylcarbamazine, is a critical medication used to combat several of these parasitic worm infections, including filariasis and loiasis.

Eofil Tablet is an anthelmintic medication primarily used to treat various parasitic infections caused by certain types of worms. Its active ingredient, Diethylcarbamazine, works by killing the parasitic worms in the bloodstream and tissues, providing relief from associated symptoms. The medication is effective against both the larval and adult forms of filarial worms.

Cenocide, a brand name for the anti-parasitic drug diethylcarbamazine (DEC), is primarily used in tropical and subtropical regions to treat a variety of filarial worm infections. First developed in 1947, this medication works by immobilizing and killing the microfilariae, or immature larvae, in the bloodstream.

Hetrazan Tablet, containing the active ingredient Diethylcarbamazine Citrate (DEC), is a powerful anthelmintic agent used primarily to treat a range of parasitic worm infections. This medication works by targeting and eliminating both the larval and adult forms of specific parasitic worms, making it a key component in combating diseases like filariasis and tropical pulmonary eosinophilia.

According to the World Health Organization, lymphatic filariasis, a parasitic disease treated by medications like Eofil Forte, affects millions of people globally. A common search query, *What is Eiffel Forte used for?*, is based on a misspelling of the prescription medication **Eofil Forte**, a combination drug used to combat parasitic infestations and their associated allergic reactions.

First documented in 1948 by Italian physician Luigi Mazzotti, the Mazzotti reaction is a complex and potentially severe inflammatory syndrome triggered by the treatment of certain parasitic infections. It is most notoriously associated with the use of the drug diethylcarbamazine (DEC) for onchocerciasis, or river blindness.